Medicare Enrolled

Dr. Paul Hemrick, D.O.

Family Medicine · Naples, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
1855 VETERANS PARK DR STE 101, Naples, FL 34109
2392600782
In practice since 2015 (11 years)
NPI: 1801281589 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hemrick from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hemrick? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hemrick

Dr. Paul Hemrick is a family medicine in Naples, FL, with 11 years in practice. Based on federal Medicare data, Dr. Hemrick performed 8,952 Medicare services across 5,265 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hemrick received a total of $3,379 from 25 pharmaceutical and/or device companies across 127 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hemrick is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice▲ Top 3% volume in FL$ $3,379 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,952
Medicare services
Top 3% in FL for family medicine
5,265
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~814 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)1,801$18$46
Office visit, established patient (30-39 min)1,428$88$264
Blood draw (venipuncture)856$8$17
Comprehensive metabolic blood panel673$10$21
Complete blood count (CBC) with differential572$8$16
Annual wellness visit, follow-up496$131$267
Lipid panel (cholesterol and triglycerides)452$13$27
Annual depression screening359$19$38
Hemoglobin A1c test (diabetes monitoring)265$10$19
Thyroid stimulating hormone (TSH) test155$16$34
Prostate cancer screening; prostate specific antigen test (psa)137$19$39
Office visit, established patient (20-29 min)127$62$187
Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use125$282$576
Pneumonia vaccine administration125$32$64
Free thyroxine (T4) test119$9$18
Drug injection, under skin or into muscle109$10$31
Flu vaccine administration100$32$64
Flu vaccine, high-dose98$72$145
Urine microalbumin test (kidney screening)78$6$12
Creatinine test (kidney function)78$5$10
New patient office visit (45-59 min)72$85$347
Vitamin B-12 level test66$15$30
Vitamin D level test64$29$59
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg62$1$3
Automated urinalysis60$2$4
Ferritin level test (iron stores)40$13$27
Iron level test40$6$13
Iron binding capacity test40$9$17
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and38$41$107
Urinalysis with microscopic exam36$3$6
PSA test (prostate cancer screening)36$18$37
Folic acid level test35$14$29
Basic metabolic blood panel34$8$17
Transitional care management services for problem of at least moderate complexity32$160$420
Urine culture, bacterial colony count30$8$16
Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment26$168$343
Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report24$8$30
Electrocardiogram (EKG), 12-lead21$11$30
Office visit, established patient, complex (40-54 min)16$145$371
C-reactive protein test (inflammation marker)15$5$10
Transitional care management services for problem of high complexity12$218$570
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,379
Total received (2019-2024)
Avg $563/year across 6 years
Top 15% in FL for family medicine
25
Companies
127
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,379 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$88
2023
$743
2022
$704
2021
$298
2020
$227
2019
$1,318

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$482
PFIZER INC.
$458
Novo Nordisk Inc
$457
Boehringer Ingelheim Pharmaceuticals, Inc.
$351
AstraZeneca Pharmaceuticals LP
$248
Lilly USA, LLC
$185
GlaxoSmithKline, LLC.
$150
Janssen Pharmaceuticals, Inc
$146
Medtronic, Inc.
$139
Novartis Pharmaceuticals Corporation
$133
Merck Sharp & Dohme Corporation
$123
Amarin Pharma Inc.
$105
ABBVIE INC.
$66
Merck Sharp & Dohme LLC
$55
Alnylam Pharmaceuticals Inc.
$54
SANOFI PASTEUR INC.
$52
IDORSIA PHARMACEUTICALS US INC
$34
Exact Sciences Corporation
$26
Inspire Medical Systems, Inc.
$23
Almatica Pharma LLC
$18
Takeda Pharmaceuticals U.S.A., Inc.
$17
Abbott Laboratories
$16
Supernus Pharmaceuticals, Inc.
$15
Boston Scientific Corporation
$13
Teva Pharmaceuticals USA, Inc.
$13
Top 3 companies account for 41.3% of total payments
Associated products mentioned in payments ›
AJOVY · ANORO · AREXVY · Aimovig · BREZTRI · Cologuard Collection Kit · ELIQUIS · ENTRESTO · EVENITY · FARXIGA · FLUBLOK QUADRIVALENT · FREESTYLE LIBRE · GARDASIL 9 · GRALISE · INSPIRE · JARDIANCE · MOUNJARO · NUVENT · ONPATTRO · Otezla · Ozempic · PAXLOVID · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · QELBREE · QULIPTA · QUVIVIQ · ROTATEQ · Repatha · Rybelsus · SHINGRIX · SPECTRA WAVEWRITER · STEGLATRO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · UBRELVY · Vascepa · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $38 per 100 Medicare services performed
Looking for a family medicine in Naples?
Compare family medicines in the Naples area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
315
Per 100K population
81.3
County median income
$86,173
Nearest hospital
PHYSICIANS REGIONAL MEDICAL CENTER - PINE RIDGE
3.3 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Hemrick is a clinical cardiology specialist, with above-average Medicare volume (top 3% in FL), and high industry engagement (low-engagement, top 15%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Hemrick experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Hemrick performed 1,801 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hemrick receive payments from pharmaceutical companies?
Yes. Dr. Hemrick received a total of $3,379 from 25 companies across 127 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hemrick's costs compare to other family medicines in Naples?
Dr. Hemrick's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hemrick) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →